VIVS

Conviction 0HealthcareScan · Mon, Aug 10, 2026

VIVS$0.3635-22.33%

ResistanceSupportVol 14

Vol MA14 9.26M

May 11May 28Jun 16Jul 6Jul 23Aug 10

VivoSim Labs, INC.Biological Products, (No Diagnostic Substances)www.organovo.com ↗

Price0.3635

Change-22.33%

Gap-10.66%

Rel volume0.20×

Avg volume16.46M

Avg $ vol9.83M

SMA 200.4619

SMA 500.8436

SMA 2001.63

Price vs 50-56.91%

Price vs 200-77.75%

MA stackbearish

50/200 cross—

Supertrenddown · 0.5980

RSI (14)34

MACD hist0.02

MACD crossbull · 4d

Stoch %K / %D20 / 29

ADX (14)15

+DI / −DI30 / 20

RSI divergence—

MACD divergence—

ATR %+28.56%

ADR %20.80%

52w high4.78

52w low0.3299

From 52w high-92.40%

Above 52w low+10.18%

New 52w highNo

SqueezeOff

Bollinger width128.36%

%B0.33

Donchian pos4.40%

Donchian high1.57

Donchian low0.3080

AVWAP (52w high)1.27

vs AVWAP high-71.31%

AVWAP (52w low)0.4477

vs AVWAP low-18.81%

OBV trendUp

Chaikin MF (20)-0.49

Today vs 20d0.20×

Avg vol (14d)9.26M

Avg vol (20d)16.46M

Avg $ vol (20d)9.83M

Market cap1.27M

RS 3m (vs SPY)-72.51%

RS 6m (vs SPY)-96.04%

RS line new highNo

Trend template0/8

Technical rank3.3

1 week+8.64%

1 month-58.65%

3 months-73.85%

6 months-84.06%

1 year-79.19%

YTD-80.66%

P/E-0.09

P/B-1.16

P/S9.70

P/FCF-0.12

EPS-5.35

Div yield—

ROE—

ROA-187.42%

Debt/Eq—

Current2.38

EV/EBITDA0.33

Gross margin—

Net margin—

Rev growth-9.03%

EPS growth-456.39%

Price target—

Target upside—

Analyst rating—

Institutional0.95%

Ent. value-3.75M

Revenue26K

Net income-2.69M

Gross profit—

Free cash flow-10.83M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out—

Employees9

ListedTue, Aug 16, 2011

Free float2.54M

Float %97.5%

Short interest48.73K

Days to cover0.0d

Short volume56.6%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank3.3 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.39

Support0.3110

Days since event—

Candle confirm—

News sentiment—

Financials as of Wed, Dec 31, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in VIVS

All disclosures →

No recent disclosed trades by Congress in VIVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VIVS

No recent insider (Form 4) filings in VIVS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VIVS · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.